CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.61 USD | +2.21% |
|
+5.67% | -15.99% |
Chart calendar Charles River Laboratories International, Inc.
43722bd375edb739190b339.tvPlThvUyRR4DXD0qrxMf1i3vqcZkCyuUV2TlSteiwA.5qaNPGmDnlwVSUSk7us5LyDc0exh5G3KCWTD1k0V8kXew6wNWYWNeDlsNQ~85cab5d39f91bd9615076d9a8e508fb3
Upcoming events on Charles River Laboratories International, Inc.
Past events on Charles River Laboratories International, Inc.
| 2024-09-10 10:15 am | Baird Global Healthcare Conference |
| 2024-09-05 09:15 am | Morgan Stanley Healthcare Conference |
| 2024-08-07 09:00 am | Q2 2024 Earnings Call |
| 2024-08-07 07:00 am | Q2 2024 Earnings Release |
| 2024-06-05 10:00 am | Jefferies Global Healthcare Conference |
| 2024-06-04 11:00 am | William Blair Growth Stock Conference |
| 2024-05-09 08:30 am | Q1 2024 Earnings Call |
| 2024-05-09 07:00 am | Q1 2024 Earnings Release |
| 2024-05-08 08:00 am | Annual General Meeting |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Poster No:6181 |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Poster No:5467 |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Poster No:5315 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4703 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4413 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4224 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4191 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4186 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:4182 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Poster No:3975 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Poster No:2841 |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 540 3 522 0.52% | 3 976 3 915 1.56% | 4 129 4 107 0.54% | 3 996 | 4 152 | 4 477 |
|
EBITDA Million USD | Released Forecast Spread | 879 878 0.22% | 991 982 0.87% | 1 013 1 017 -0.4% | 996 | 1 059 | 1 160 |
|
EBIT Million USD | Released Forecast Spread | 742 738 0.51% | 834 820 1.67% | 839 842 -0.35% | 793 | 838 | 926 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 481 449 7.01% | 623 568 9.63% | 581 513 13.41% | 407 | 580 | 741 |
|
Net income Million USD | Released Forecast Spread | 391 358 9.2% | 486 409 18.85% | 475 387 22.66% | 322 | 432 | 533 |
|
EPS USD | Released Forecast Spread | 7,60 6,99 8.67% | 9,48 7,97 18.98% | 9,22 7,49 23.07% | 6,29 | 8,07 | 10,1 |
| Announcement Date | 16/02/22 | 22/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | Juni | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 989 970 1.93% | 1 100 1 035 6.26% | 1 029 986 4.39% | 1 060 1 054 0.59% | 1 027 1 000 2.61% | 1 013 991 2.24% | 1 012 993 1.82% | 1 026 1 024 0.18% | 978 | 980 | 1 007 | 1 022 | 1 025 | 1 052 | 1 084 | 1 088 |
|
EBITDA Million USD | Released Forecast Spread | 240 238 1.14% | 267 260 2.72% | 260 252 3.03% | 260 258 0.62% | 255 241 5.8% | 239 242 -1.38% | 233 222 4.94% | 266 243 9.71% | 240 | 249 | 254 | 261 | 256 | 270 | 275 | 277 |
|
EBIT Million USD | Released Forecast Spread | 201 197 2.26% | 225 213 5.33% | 218 209 3.98% | 216 213 1.41% | 211 194 8.51% | 194 196 -1% | 187 178 5.43% | 219 196 11.62% | 191 | 197 | 199 | 208 | 208 | 219 | 218 | 228 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 123 128 -3.67% | 245 155 57.85% | 131 150 -12.47% | 129 143 -10.32% | 113 120 -6.11% | 209 120 74.62% | 99,0 96,3 2.82% | 120 111 7.99% | 87,9 | 94,3 | 119 | 125 | 128 | 143 | ||
|
Net income Million USD | Released Forecast Spread | 96,5 98,4 -1.95% | 187 109 71.19% | 103 102 0.7% | 97,0 105 -7.26% | 87,4 88,9 -1.74% | 187 92,4 102.53% | 67,3 71,2 -5.45% | 90,0 83,9 7.32% | 78,2 | 82,2 | 96,6 | 95,9 | 99,8 | 111 | 118 | 111 |
|
EPS USD | Released Forecast Spread | 1,88 1,84 2.12% | 3,65 2,14 70.86% | 2,01 1,99 0.87% | 1,89 2,04 -7.23% | 1,69 1,68 0.51% | 3,62 1,78 103.94% | 1,30 1,35 -3.7% | 1,74 1,68 3.88% | 1,56 | 1,62 | 1,83 | 1,88 | 1,96 | 2,14 | 2,28 | 2,15 |
| Announcement Date | 02/11/22 | 22/02/23 | 11/05/23 | 09/08/23 | 08/11/23 | 14/02/24 | 09/05/24 | 07/08/24 | - | - | - | - | - | - | - | - |
More events
Past sector events for Charles River Laboratories International, Inc.
| 2024-09-09 04:01 pm | ABIVAX: Q2 2024 Earnings Release |
| 2024-09-05 02:00 am | GENUS PLC: Q4 2024 Earnings Release |
| 2024-08-29 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q2 2024 Earnings Release |
| 2024-08-29 02:00 am | BIOARCTIC AB: Q2 2024 Earnings Release |
| 2024-08-28 07:27 pm | MESOBLAST LIMITED: Q4 2024 Earnings Release |
| 2024-08-28 | R&G PHARMASTUDIES CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-28 | MORPHOSYS AG: Q2 2024 Earnings Release |
| 2024-08-28 02:00 am | PURETECH HEALTH PLC: Q2 2024 Earnings Release |
| 2024-08-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q2 2024 Earnings Release |
| 2024-08-27 04:00 am | OCULIS HOLDING AG: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRL Stock
- Calendar Charles River Laboratories International, Inc.